Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001325812-09-000014
Filing Date
2009-06-12
Accepted
2009-06-12 16:14:51
Documents
1
Period of Report
2009-06-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3536
  Complete submission text file 0001325812-09-000014.txt   5352
Mailing Address 300 THIRD STREET CAMBRIDGE MA 02142
Business Address 300 THIRD STREET CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Issuer) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address GENZYME CORP ONE KENDALL SQUARE CAMBRIDGE MA 02139
Business Address
DZAU VICTOR J (Reporting) CIK: 0001201252 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50743 | Film No.: 09889991